Anthony G. Quinn
CIK 1532219 · View on SEC EDGAR ↗
First SEC filing: April 6, 2016 · Latest: Feb. 14, 2022
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 16, 2022 | SYRE | P | 80,079 | $2.34 | $187,385 | 550,540 Direct | +17.02% | Acquired | 86.6% (price as of 2026-08-21) |
| March 15, 2022 | SYRE | P | 42,417 | $1.86 | $78,896 | 473,461 Direct | +9.84% | Acquired | 134.8% (price as of 2026-08-21) |
| March 14, 2022 | SYRE | P | 67,472 | $1.93 | $130,221 | 431,044 Direct | +18.56% | Acquired | 126.3% (price as of 2026-08-21) |
| March 11, 2022 | SYRE | P | 34,777 | $2.06 | $71,641 | 363,572 Direct | +10.58% | Acquired | 112.0% (price as of 2026-08-21) |
| Dec. 10, 2021 | SYRE | P | 10,526 | $3.75 | $39,472 | 328,795 Direct | +3.31% | Acquired | 16.5% (price as of 2026-08-21) |
| Dec. 9, 2021 | SYRE | P | 43,108 | $3.70 | $159,500 | 318,269 Direct | +15.67% | Acquired | 18.0% (price as of 2026-08-21) |
| April 30, 2020 | SYRE | P | 165,000 | $4.75 | $783,750 | 538,469 Direct | +44.18% | Acquired | -8.1% (price as of 2026-08-21) |
| Dec. 8, 2017 | SYRE | P | 600 | $5.07 | $3,042 | 35,409 Direct | +1.72% | Acquired | -13.9% (price as of 2026-08-21) |
| Dec. 7, 2017 | SYRE | P | 2,800 | $4.99 | $13,972 | 34,809 Direct | +8.75% | Acquired | -12.5% (price as of 2026-08-21) |
| Dec. 6, 2017 | SYRE | P | 4,888 | $4.92 | $24,049 | 32,009 Direct | +18.02% | Acquired | -11.2% (price as of 2026-08-21) |
| Dec. 5, 2017 | SYRE | P | 5,065 | $4.93 | $24,970 | 27,121 Direct | +22.96% | Acquired | -11.4% (price as of 2026-08-21) |
| Dec. 4, 2017 | SYRE | P | 7,956 | $4.98 | $39,621 | 22,056 Direct | +56.43% | Acquired | -12.3% (price as of 2026-08-21) |
| Dec. 1, 2017 | SYRE | P | 4,100 | $4.53 | $18,573 | 14,100 Direct | +41.00% | Acquired | -3.6% (price as of 2026-08-21) |
| April 12, 2016 | SYRE | P | 10,000 | $10.00 | $100,000 | 10,000 Direct | — | Acquired | -56.3% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 17, 2022 | SYRE | Employee Stock Option (right to buy) | Common Stock (350,000) | $3.17 | Feb. 16, 2032 | 350,000 | Acquired |
| Feb. 17, 2021 | SYRE | Employee Stock Option (right to buy) | Common Stock (330,000) | $7.35 | Feb. 16, 2031 | 330,000 | Acquired |
| July 18, 2018 | SYRE | Employee Stock Option (right to buy) | Common Stock (50,000) | $9.36 | July 17, 2028 | 50,000 | Acquired |
| July 18, 2018 | SYRE | Employee Stock Option (right to buy) | Common Stock (75,000) | $9.36 | July 17, 2028 | 75,000 | Acquired |
| July 18, 2018 | SYRE | Employee Stock Option (right to buy) | Common Stock (75,000) | $9.36 | July 17, 2028 | 75,000 | Acquired |
| July 18, 2018 | SYRE | Employee Stock Option (right to buy) | Common Stock (300,000) | $9.36 | July 17, 2028 | 300,000 | Acquired |
| July 12, 2018 | SYRE | Director Stock Option (right to buy) | Common Stock (14,866) | $6.31 | Feb. 19, 2028 | 14,866 | Disposed |
| July 12, 2018 | SYRE | Director Stock Option (right to buy) | Common Stock (24,000) | $7.04 | April 20, 2027 | 24,000 | Disposed |
| July 11, 2018 | SYRE | Director Stock Option (right to buy) | Common Stock (3,307) | $5.46 | March 17, 2026 | 3,307 | Disposed |
| Feb. 20, 2018 | SYRE | Employee Stock Option (right to buy) | Common Stock (178,400) | $6.31 | Feb. 19, 2028 | 178,400 | Acquired |
| Feb. 15, 2018 | SYRE | Director Stock Option (right to buy) | Common Stock (15,211) | $5.46 | March 17, 2026 | 15,211 | Disposed |
| Aug. 31, 2017 | SYRE | Employee Stock Option (right to buy) | Common Stock (150,000) | $4.11 | Aug. 30, 2027 | 150,000 | Acquired |
| April 21, 2017 | SYRE | Employee Stock Option (right to buy) | Common Stock (24,000) | $7.04 | April 20, 2027 | 24,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| April 6, 2016 | SYRE | Director Stock Option (right to buy)→ Common Stock (23,809) | 23,809 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $424,429 | — | — | — | — | — | $1,188,200 | $2,392,254 |
| 2021 | $560,000 | — | — | — | $332,000 | — | $29,661 | $2,623,186 |
| 2020 | $538,000 | — | — | — | $256,000 | — | $25,745 | $2,909,606 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.